Pfizer Limited Asset Resilience Ratio

Latest as of March 2026: 60.66%

Pfizer Limited asset resilience ratio. Pfizer Limited (PFIZER) has an Asset Resilience Ratio of 60.66% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PFIZER defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs29.86 Billion

≈ $322.90 Million USD Cash + Short-term Investments

Total Assets

Rs49.22 Billion

≈ $532.28 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Pfizer Limited (2005–2026)

Asset resilience ratio of Pfizer Limited from 2005 to 2026. This chart shows how Pfizer Limited's Asset Resilience Ratio has changed over time. Read PFIZER total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Pfizer Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Pfizer Limited asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs29.86 Billion	60.66%
Total Liquid Assets	Rs29.86 Billion	60.66%

Asset Resilience Insights

Very High Liquidity: Pfizer Limited maintains exceptional liquid asset reserves at 60.66% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Pfizer Limited Industry Peers by Asset Resilience Ratio

Compare Pfizer Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
AstraZeneca PLC NASDAQ:AZN	Drug Manufacturers - General	0.10%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.33%
Cosmo Pharmaceuticals N.V F:C43	Drug Manufacturers - General	10.92%
Zhejiang Int'L Group Co Ltd SHE:000411	Drug Manufacturers - General	0.00%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	6.46%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	6.34%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	Drug Manufacturers - General	17.40%

Pfizer Limited Asset Resilience Ratio by Year (2005–2026)

Pfizer Limited asset resilience ratio by year from 2005 to 2026. The table below shows the annual Asset Resilience Ratio data for Pfizer Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	60.66%	Rs29.86 Billion ≈ $322.90 Million	Rs49.22 Billion ≈ $532.28 Million	+4.04pp
2025-03-31	56.62%	Rs27.81 Billion ≈ $300.72 Million	Rs49.11 Billion ≈ $531.12 Million	+8.80pp
2024-03-31	47.82%	Rs20.22 Billion ≈ $218.70 Million	Rs42.29 Billion ≈ $457.33 Million	+2.04pp
2023-03-31	45.79%	Rs18.32 Billion ≈ $198.10 Million	Rs40.01 Billion ≈ $432.66 Million	+5.25pp
2022-03-31	40.54%	Rs15.81 Billion ≈ $171.01 Million	Rs39.01 Billion ≈ $421.83 Million	+8.66pp
2021-03-31	31.88%	Rs10.41 Billion ≈ $112.59 Million	Rs32.66 Billion ≈ $353.19 Million	-17.70pp
2020-03-31	49.58%	Rs21.84 Billion ≈ $236.21 Million	Rs44.05 Billion ≈ $476.43 Million	+2.02pp
2019-03-31	47.55%	Rs18.74 Billion ≈ $202.63 Million	Rs39.40 Billion ≈ $426.09 Million	+0.81pp
2018-03-31	46.75%	Rs17.25 Billion ≈ $186.56 Million	Rs36.90 Billion ≈ $399.06 Million	+1.28pp
2017-03-31	45.47%	Rs14.87 Billion ≈ $160.81 Million	Rs32.71 Billion ≈ $353.71 Million	+45.32pp
2016-03-31	0.15%	Rs43.26 Million ≈ $467.81K	Rs29.14 Billion ≈ $315.11 Million	+0.15pp
2012-03-31	0.00%	Rs500.00K ≈ $5.41K	Rs15.76 Billion ≈ $170.49 Million	-39.68pp
2011-03-31	39.68%	Rs5.50 Billion ≈ $59.49 Million	Rs13.86 Billion ≈ $149.92 Million	+8.76pp
2010-03-31	30.92%	Rs3.72 Billion ≈ $40.24 Million	Rs12.03 Billion ≈ $130.14 Million	+8.33pp
2009-03-31	22.59%	Rs2.48 Billion ≈ $26.82 Million	Rs10.98 Billion ≈ $118.71 Million	-30.54pp
2008-03-31	53.13%	Rs4.61 Billion ≈ $49.85 Million	Rs8.67 Billion ≈ $93.81 Million	+42.82pp
2007-03-31	10.31%	Rs666.73 Million ≈ $7.21 Million	Rs6.47 Billion ≈ $69.92 Million	-1.16pp
2006-03-31	11.47%	Rs660.82 Million ≈ $7.15 Million	Rs5.76 Billion ≈ $62.30 Million	-1.92pp
2005-03-31	13.39%	Rs699.09 Million ≈ $7.56 Million	Rs5.22 Billion ≈ $56.47 Million	--

pp = percentage points

About Pfizer Limited

NSE:PFIZER India Drug Manufacturers - General

Market Cap

$1.89 Billion

Rs174.83 Billion INR

Market Cap Rank

#6110 Global

#276 in India

Share Price

Rs3821.60

Change (1 day)

+5.03%

52-Week Range

Rs3612.30 - Rs5197.80

All Time High

Rs6318.30